TIDMSN.

RNS Number : 7852S

Smith & Nephew Plc

13 March 2023

SMITH & NEPHEW PLC

13 March 2023

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

   1.   VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010 AND 2020 

On 9 March 2023, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010 and 2020.

i. FINAL VESTING ON 9 MARCH 2023 OF 2020 EQUITY INCENTIVE PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

The awards were granted under the Global Share Plan 2010 on 9 March 2020. One third of the Shares vested on 9 March 2021, a further third vested on 9 March 2022 and the final third vested on 9 March 2023. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards. The number of Shares acquired includes the dividend equivalent Shares which participants receive on vested Shares.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            -------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            -------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            -------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            -------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            -------------------------------------------- 
 Nature of the transaction   Final vesting of Equity Incentive Programme 
                              awards granted on 9 March 2020 under 
                              the Smith & Nephew Global Share Plan 
                              2010 . 
                            -------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            -------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            -------------------------------------------- 
 
 
                                                                                               Total Ordinary 
                                                                                                Share Holding 
                                                                            Total Ordinary      as a % of 
                                                                             Share Holding      the Company's 
                                                                             following          ISC following 
 Name                               Price                    Aggregated      the transaction    the transaction 
  (Position)              Status     (GBP)      Volume        information    *                  * 
                                                2,431 
                                                 (of which 
 Helen Barraclough                               1,147 
  (Group General                                 were sold                  24,788.24771 
  Counsel and                                    and 1,284   N/A Single      ordinary 
  Company Secretary)    PDMR        12.161358    retained)    Transaction    shares            0.00282% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                5,852 
                                                 (of which 
 Bradley Cannon                                  1,978 
  (President,                                    were sold                  105,081.37494 
  Orthopaedics                                   and 3,874   N/A Single      ordinary 
  & Americas)           PDMR        12.161358    retained)    Transaction    shares            0.01197% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                3,916 
 Phil Cowdy                                      (of which 
  (Chief Corporate                               1,847 
  Development                                    were sold                  49,202.99309 
  and Corporate                                  and 2,069   N/A Single      ordinary 
  Affairs Officer)      PDMR        12.161358    retained)    Transaction    shares            0.00561% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                3,053 
                                                 (of which 
 Myra Eskes                                      0 were 
  (President                                     sold and                   30,586.36775 
  APAC and                                       3,053       N/A Single      ordinary 
  Global Service)       PDMR        12.161358    retained)    Transaction    shares            0.00348% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                3,894 
 Simon Fraser                                    (of which 
  (President,                                    1,159 
  AWM and Global                                 were sold                  30,486.86880 
  Commercial                                     and 2,735   N/A Single      ordinary 
  Operations)           PDMR        12.161358    retained)    Transaction    shares            0.00347% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                5,230 
                                                 (of which 
                                                 2,065 
 Elga Lohler                                     were sold                  127,175.00000 
  (Chief HR                                      and 3,165   N/A Single      ordinary 
  Officer)              PDMR        12.161358    retained)    Transaction    shares            0.01449% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                5,065 
 Vasant Padmanabhan                              (of which 
  (President                                     1,982 
  Research                                       were sold                  84,289.00000 
  & Development                                  and 3,083   N/A Single      ordinary 
  and ENT)              PDMR        12.161358    retained)    Transaction    shares            0.00960% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
 Scott Schaffner                                3,118 
  (Executive                                     (of which 
  Vice President                                 928 were 
  and General                                    sold and                   60,629.43173 
  Manager Sports                                 2,190       N/A Single      ordinary 
  Medicine)             PDMR        12.161358    retained)    Transaction    shares            0.00691% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

ii. PARTIAL VESTING ON 9 MARCH 2023 OF 2021 EQUITY INCENTIVE PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

The awards were granted under the Global Share Plan 2020 on 9 March 2021. One third of the Shares vested on 9 March 2022, a further third vested on 9 March 2023 and the final third will vest on 9 March 2024. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards. The number of Shares acquired includes the dividend equivalent Shares which participants receive on vested Shares.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ---------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ---------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ---------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            ---------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ---------------------------------------------- 
 Nature of the transaction   Partial vesting of Equity Incentive Programme 
                              awards granted on 9 March 2021 under 
                              the Smith & Nephew Global Share Plan 
                              2020 . 
                            ---------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            ---------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ---------------------------------------------- 
 
 
                                                                                               Total Ordinary 
                                                                                                Share Holding 
                                                                            Total Ordinary      as a % of 
                                                                             Share Holding      the Company's 
                                                                             following          ISC following 
 Name                               Price                    Aggregated      the transaction    the transaction 
  (Position)              Status     (GBP)      Volume        information    *                  * 
                                                3,006 
                                                 (of which 
 Helen Barraclough                               1,418 
  (Group General                                 were sold                  26,376.24771 
  Counsel and                                    and 1,588   N/A Single      ordinary 
  Company Secretary)    PDMR        12.161358    retained)    Transaction    shares            0.00301% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                6,860 
                                                 (of which 
 Bradley Cannon                                  2,317 
  (President,                                    were sold                  109,624.37494 
  Orthopaedics                                   and 4,543   N/A Single      ordinary 
  & Americas)           PDMR        12.161358    retained)    Transaction    shares            0.01249% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                5,501 
 Phil Cowdy                                      (of which 
  (Chief Corporate                               2,595 
  Development                                    were sold                  52,108.99309 
  and Corporate                                  and 2,906   N/A Single      ordinary 
  Affairs Officer)      PDMR        12.161358    retained)    Transaction    shares            0.00594% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                5,985 
                                                 (of which 
 Myra Eskes                                      0 were 
  (President                                     sold and                   36,571.36775 
  APAC and                                       5,985       N/A Single      ordinary 
  Global Service)       PDMR        12.161358    retained)    Transaction    shares            0.00417% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                4,973 
 Simon Fraser                                    (of which 
  (President,                                    1,480 
  AWM and Global                                 were sold                  33,979.86880 
  Commercial                                     and 3,493   N/A Single      ordinary 
  Operations)           PDMR        12.161358    retained)    Transaction    shares            0.00387% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                6,130 
                                                 (of which 
                                                 2,421 
 Elga Lohler                                     were sold                  130,884.00000 
  (Chief HR                                      and 3,709   N/A Single      ordinary 
  Officer)              PDMR        12.161358    retained)    Transaction    shares            0.01491% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                5,083 
 Vasant Padmanabhan                              (of which 
  (President                                     1,990 
  Research                                       were sold                  87,382.00000 
  & Development                                  and 3,093   N/A Single      ordinary 
  and ENT)              PDMR        12.161358    retained)    Transaction    shares            0.00996% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
 Scott Schaffner                                3,452 
  (Executive                                     (of which 
  Vice President                                 1,027 
  and General                                    were sold                  63,054.43173 
  Manager Sports                                 and 2,425   N/A Single      ordinary 
  Medicine)             PDMR        12.161358    retained)    Transaction    shares            0.00718% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

iii. PARTIAL VESTING ON 9 MARCH 2023 OF 2022 DEFERRED BONUS SHARE PLAN AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

The awards were granted under the Global Share Plan 2020 on 9 March 2022. One third of the Shares vested on 9 March 2023, a further third will vest on 9 March 2024 and the final third will vest on 9 March 2025. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards. The number of Shares acquired includes the dividend equivalent Shares which participants receive on vested Shares.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            ------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------- 
 Nature of the transaction   Partial vesting of Deferred Bonus Share 
                              Plan awards granted on 9 March 2022 under 
                              the Smith & Nephew Global Share Plan 
                              2020 . 
                            ------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            ------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------- 
 
 
                                                                                                   Total Ordinary 
                                                                                                    Share Holding 
                                                                                Total Ordinary      as a % of 
                                                                                 Share Holding      the Company's 
                                                                                 following          ISC following 
 Name                               Price                        Aggregated      the transaction    the transaction 
  (Position)              Status     (GBP)      Volume            information    *                  * 
                                                1,717 
 Helen Barraclough                               (of which 
  (Group General                                 810 were                       27,283.24771 
  Counsel and                                    sold and        N/A Single      ordinary 
  Company Secretary)    PDMR        12.161358    907 retained)    Transaction    shares            0.00311% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                6,229 
                                                 (of which 
 Bradley Cannon                                  2,105 
  (President,                                    were sold                      113,748.37494 
  Orthopaedics                                   and 4,124       N/A Single      ordinary 
  & Americas)           PDMR        12.161358    retained)        Transaction    shares            0.01296% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                2,815 
 Phil Cowdy                                      (of which 
  (Chief Corporate                               1,328 
  Development                                    were sold                      53,595.99309 
  and Corporate                                  and 1,487       N/A Single      ordinary 
  Affairs Officer)      PDMR        12.161358    retained)        Transaction    shares            0.00611% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                4,058 
                                                 (of which 
 Myra Eskes                                      0 were 
  (President                                     sold and                       40,629.36775 
  APAC and                                       4,058           N/A Single      ordinary 
  Global Service)       PDMR        12.161358    retained)        Transaction    shares            0.00463% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                6,041 
 Simon Fraser                                    (of which 
  (President,                                    1,797 
  AWM and Global                                 were sold                      38,223.86880 
  Commercial                                     and 4,244       N/A Single      ordinary 
  Operations)           PDMR        12.161358    retained)        Transaction    shares            0.00436% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                712 (of 
 Mizanu Kebede                                   which 
  (Chief Quality                                 269 were                       5,476.65944 
  & Regulatory                                   sold and        N/A Single      ordinary 
  Officer)              PDMR        12.161358    443 retained)    Transaction    shares            0.00062% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                4,017 
                                                 (of which 
                                                 1,586 
 Elga Lohler                                     were sold                      133,315.00000 
  (Chief HR                                      and 2,431       N/A Single      ordinary 
  Officer)              PDMR        12.161358    retained)        Transaction    shares            0.01519% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
                                                3,250 
 Vasant Padmanabhan                              (of which 
  (President                                     1,272 
  Research                                       were sold                      89,360.00000 
  & Development                                  and 1,978       N/A Single      ordinary 
  and ENT)              PDMR        12.161358    retained)        Transaction    shares            0.01018% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
 Scott Schaffner                                2,361 
  (Executive                                     (of which 
  Vice President                                 703 were 
  and General                                    sold and                       64,712.43173 
  Manager Sports                                 1,658           N/A Single      ordinary 
  Medicine)             PDMR        12.161358    retained)        Transaction    shares            0.00737% 
                       ----------  ----------  ---------------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

iv. FINAL VESTING ON 9 MARCH 2023 OF SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE 2020 PERFORMANCE SHARE PROGRAMME AWARDS:

The awards were granted under the Global Share Plan 2020 on 8 March 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            ------------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------------- 
 Nature of the transaction   Final vesting on 9 March 2023 of Supplementary 
                              Awards granted under the Smith & Nephew 
                              Global Share Plan 2020 for the 2020 Performance 
                              Share Programme awards . 
                            ------------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            ------------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------------- 
 
 
                                                                                               Total Ordinary 
                                                                                                Share Holding 
                                                                            Total Ordinary      as a % of 
                                                                             Share Holding      the Company's 
                                                                             following          ISC following 
 Name                               Price                    Aggregated      the transaction    the transaction 
  (Position)              Status     (GBP)      Volume        information    *                  * 
                                                2,745 
                                                 (of which 
 Helen Barraclough                               1,295 
  (Group General                                 were sold                  28,733.24771 
  Counsel and                                    and 1,450   N/A Single      ordinary 
  Company Secretary)    PDMR        12.161358    retained)    Transaction    shares            0.00327% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                7,406 
                                                 (of which 
 Bradley Cannon                                  2,503 
  (President,                                    were sold                  118,651.37494 
  Orthopaedics                                   and 4,903   N/A Single      ordinary 
  & Americas)           PDMR        12.161358    retained)    Transaction    shares            0.01352% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                4,965 
 Phil Cowdy                                      (of which 
  (Chief Corporate                               2,342 
  Development                                    were sold                  56,218.99309 
  and Corporate                                  and 2,623   N/A Single      ordinary 
  Affairs Officer)      PDMR        12.161358    retained)    Transaction    shares            0.00641% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                7,348 
                                                 (of which 
 Myra Eskes                                      0 were 
  (President                                     sold and                   47,977.36775 
  APAC and                                       7,348       N/A Single      ordinary 
  Global Service)       PDMR        12.161358    retained)    Transaction    shares            0.00547% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                6,407 
 Simon Fraser                                    (of which 
  (President,                                    1,907 
  AWM and Global                                 were sold                  42,723.86880 
  Commercial                                     and 4,500   N/A Single      ordinary 
  Operations)           PDMR        12.161358    retained)    Transaction    shares            0.00487% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                6,618 
                                                 (of which 
                                                 2,614 
 Elga Lohler                                     were sold                  137,319.00000 
  (Chief HR                                      and 4,004   N/A Single      ordinary 
  Officer)              PDMR        12.161358    retained)    Transaction    shares            0.01565% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                                6,409 
 Vasant Padmanabhan                              (of which 
  (President                                     2,509 
  Research                                       were sold                  93,260.00000 
  & Development                                  and 3,900   N/A Single      ordinary 
  and ENT)              PDMR        12.161358    retained)    Transaction    shares            0.01063% 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
 Scott Schaffner                                3,731 
  (Executive                                     (of which 
  Vice President                                 1,111 
  and General                                    were sold                  67,332.43173 
  Manager Sports                                 and 2,620   N/A Single      ordinary 
  Medicine)             PDMR        12.161358    retained)    Transaction    shares            0.00767 % 
                       ----------  ----------  -----------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

v. FINAL VESTING ON 9 MARCH 2023 OF CONDITIONAL SHARE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

The awards were granted under the Global Share Plan 2010 on 9 March 2020. One quarter of the shares vested on 9 March 2021, a further quarter vested on 9 March 2022 and the remainder vested on 9 March 2023. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            ------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------- 
 Nature of the transaction   Final vesting of a Conditional Share Award 
                              granted on 9 March 2020 under the Smith 
                              & Nephew Global Share Plan 2010. 
                            ------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            ------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------- 
 
 
                                                                                              Total Ordinary 
                                                                                               Share Holding 
                                                                           Total Ordinary      as a % of 
                                                                            Share Holding      the Company's 
                                                                            following          ISC following 
 Name                              Price                    Aggregated      the transaction    the transaction 
  (Position)             Status     (GBP)      Volume        information    *                  * 
                                               13,091 
                                                (of which 
 Bradley Cannon                                 4,423 
  (President,                                   were sold                  127,319.37494 
  Orthopaedics                                  and 8,668   N/A Single      ordinary 
  & Americas)          PDMR        12.161358    retained)    Transaction    shares            0.01451% 
                      ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                               9,208 
 Phil Cowdy                                     (of which 
  (Chief Corporate                              4,343 
  Development                                   were sold                  61,083.99309 
  and Corporate                                 and 4,865   N/A Single      ordinary 
  Affairs Officer)     PDMR        12.161358    retained)    Transaction    shares            0.00696% 
                      ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                               13,189 
                                                (of which 
 Myra Eskes                                     0 were 
  (President                                    sold and                   61,166.36775 
  APAC and                                      13,189      N/A Single      ordinary 
  Global Service)      PDMR        12.161358    retained)    Transaction    shares            0.00697% 
                      ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                               11,218 
 Simon Fraser                                   (of which 
  (President,                                   3,338 
  AWM and Global                                were sold                  50,603.86880 
  Commercial                                    and 7,880   N/A Single      ordinary 
  Operations)          PDMR        12.161358    retained)    Transaction    shares            0.00577% 
                      ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                               11,699 
                                                (of which 
                                                4,620 
 Elga Lohler                                    were sold                  144,398.00000 
  (Chief HR                                     and 7,079   N/A Single      ordinary 
  Officer)             PDMR        12.161358    retained)    Transaction    shares            0.01645% 
                      ----------  ----------  -----------  -------------  -----------------  ----------------- 
                                               11,221 
 Vasant Padmanabhan                             (of which 
  (President                                    4,392 
  Research                                      were sold                  100,089.00000 
  & Development                                 and 6,829   N/A Single      ordinary 
  and ENT)             PDMR        12.161358    retained)    Transaction    shares            0.01140% 
                      ----------  ----------  -----------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

   2.   AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020 

On 9 March 2023, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Smith & Nephew Global Share Plan 2020. The awards have been made in London and are based on the closing Share price on the London Stock Exchange on 8 March 2023 of GBP12.09.

   i.   DEFERRED BONUS PLAN AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020: 

A portion of the annual bonus earned by the following PDMRs for performance during the year to 31 December 2022 has been deferred into a share award. These awards will normally vest in equal annual tranches over three years following the award date, subject to continued achievement of objectives and employment. In the event that objectives are not met in any of the three years, the portion of shares due to vest on the following anniversary will lapse. Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            -------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            -------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            -------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc Ordinary Shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            -------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            -------------------------------------------- 
 Nature of the transaction   Deferred Bonus Plan awards granted on 9 
                              March 2023 under the Smith & Nephew Global 
                              Share Plan 2020. 
                            -------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            -------------------------------------------- 
 Place of Transaction        Grant took place outside a trading venue 
                            -------------------------------------------- 
 
 
 Name                        Status   Price      Volume   Aggregated information 
  (Position)                           (GBP) 
 Helen Barraclough           PDMR     GBP12.09   5,004    N/A Single Transaction 
  (Group General 
  Counsel and Company 
  Secretary) 
                            -------  ---------  -------  ----------------------- 
 Bradley Cannon              PDMR     GBP12.09   8,226    N/A Single Transaction 
  (President, Orthopaedics 
  & Americas) 
                            -------  ---------  -------  ----------------------- 
 Paul Connolly               PDMR     GBP12.09   5,670    N/A Single Transaction 
  (President, Global 
  Operations) 
                            -------  ---------  -------  ----------------------- 
 Phil Cowdy                  PDMR     GBP12.09   5,392    N/A Single Transaction 
  (Chief Corporate 
  Development and 
  Corporate Affairs 
  Officer) 
                            -------  ---------  -------  ----------------------- 
 Myra Eskes                  PDMR     GBP12.09   18,282   N/A Single Transaction 
  (President APAC 
  and Global Service) 
                            -------  ---------  -------  ----------------------- 
 Mizanu Kebede               PDMR     GBP12.09   5,798    N/A Single Transaction 
  (Chief Quality 
  & Regulatory Officer) 
                            -------  ---------  -------  ----------------------- 
 Elga Lohler                 PDMR     GBP12.09   8,485    N/A Single Transaction 
  (Chief HR Officer) 
                            -------  ---------  -------  ----------------------- 
 Vasant Padmanabhan          PDMR     GBP12.09   6,902    N/A Single Transaction 
  (President Research 
  & Development and 
  ENT) 
                            -------  ---------  -------  ----------------------- 
 Alison Parkes               PDMR     GBP12.09   2,999    N/A Single Transaction 
  (Chief Compliance 
  Officer) 
                            -------  ---------  -------  ----------------------- 
 Scott Schaffner             PDMR     GBP12.09   2,771    N/A Single Transaction 
  (Executive Vice 
  President and General 
  Manager Sports 
  Medicine) 
                            -------  ---------  -------  ----------------------- 
 

ii. PERFORMANCE SHARE PROGRAMME 2023 AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020

The Remuneration Committee has approved performance conditions attached to the vesting of these awards, which are detailed below. These awards will vest on 9 March 2026, subject to the achievement of the performance conditions which are measured over the period 1 January 2023 to 31 December 2025 as set out below.

The number of shares subject to the above awards are shown at target vesting. Should maximum vesting be achieved, participants will receive 2x the number of shares shown below. Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

The following relates to all individuals included in this section:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc Ordinary Shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            ------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------- 
 Nature of the transaction   Performance Share Awards granted at target 
                              on 9 March 2023 under the Smith & Nephew 
                              Global Share Plan 2020. 
                            ------------------------------------------- 
 Date of Transaction         2023 - 03 - 09 
                            ------------------------------------------- 
 Place of Transaction        Grant took place outside a trading venue 
                            ------------------------------------------- 
 
 
                             Director                            Aggregated 
 Name (Position)              / PDMR     Price (GBP)   Volume     information 
 Helen Barraclough           PDMR        GBP12.09      31,116    N/A Single Transaction 
  (Group General 
  Counsel and Company 
  Secretary) 
                            ----------  ------------  --------  ----------------------- 
 Bradley Cannon              PDMR        GBP12.09      106,204   N/A Single Transaction 
  (President, Orthopaedics 
  & Americas) 
                            ----------  ------------  --------  ----------------------- 
 Paul Connolly               PDMR        GBP12.09      41,132    N/A Single Transaction 
  (President, Global 
  Operations) 
                            ----------  ------------  --------  ----------------------- 
 Phil Cowdy                  PDMR        GBP12.09      33,530    N/A Single Transaction 
  (Chief Corporate 
  Development and 
  Corporate Affairs 
  Officer) 
                            ----------  ------------  --------  ----------------------- 
 Myra Eskes                  PDMR        GBP12.09      53,129    N/A Single Transaction 
  (President APAC 
  and Global Service) 
                            ----------  ------------  --------  ----------------------- 
 Mizanu Kebede               PDMR        GBP12.09      42,058    N/A Single Transaction 
  (Chief Quality 
  & Regulatory 
  Officer) 
                            ----------  ------------  --------  ----------------------- 
 Elga Lohler                 PDMR        GBP12.09      51,469    N/A Single Transaction 
  (Chief HR Officer) 
                            ----------  ------------  --------  ----------------------- 
 Deepak Nath                 Executive   GBP12.09      141,874   N/A Single Transaction 
  (Chief Executive            Director 
  Officer) 
                            ----------  ------------  --------  ----------------------- 
 Anne-Françoise         Executive   GBP12.09      70,053    N/A Single Transaction 
  Nesmes                      Director 
  (Chief Financial 
  Officer) 
                            ----------  ------------  --------  ----------------------- 
 Vasant Padmanabhan          PDMR        GBP12.09      50,069    N/A Single Transaction 
  (President Research 
  & Development 
  and ENT) 
                            ----------  ------------  --------  ----------------------- 
 Alison Parkes               PDMR        GBP12.09      9,191     N/A Single Transaction 
  (Chief Compliance 
  Officer) 
                            ----------  ------------  --------  ----------------------- 
 Scott Schaffner             PDMR        GBP12.09      73,676    N/A Single Transaction 
  (Executive Vice 
  President and 
  General Manager 
  Sports Medicine) 
                            ----------  ------------  --------  ----------------------- 
 

As explained on page 138 of the 2022 Annual Report the performance conditions applying to these awards have been determined by the Remuneration Committee.

The awards made to the Executive Directors are subject to four equally weighted performance measures: Total Shareholder Return (TSR), Return on Invested Capital (ROIC), Global Revenue Growth and Cumulative Free Cash Flow. Page 138 of the 2022 Annual Report explains how TSR will be measured and defines the calculation of ROIC with reference to the methodology on page 136.

The awards are subject to TSR as follows. Details of the two equally weighted peer groups are defined on page 138 of the 2022 Annual Report.

 
                            Award vesting as % of salary at date of 
                                                              grant 
                       Sector based peer group   FTSE100 peer group 
                      ------------------------  ------------------- 
 Below the index                           Nil                  Nil 
                      ------------------------  ------------------- 
 Equaling the index                       8.6%                 8.6% 
                      ------------------------  ------------------- 
 8% above the index                      34.4%                34.4% 
                      ------------------------  ------------------- 
 

Awards vest on a straight-line basis between these points. The maximum has been set significantly above target reflecting the maximum opportunity for outperformance.

The awards are subject to ROIC as follows:

 
 Return on Invested Capital     Award vesting as a % of salary 
  Year ended 31 December 2025 
 Below 8.5%                                                Nil 
                               ------------------------------- 
 8.5%                                                    17.2% 
                               ------------------------------- 
 9.5%                                                    34.4% 
                               ------------------------------- 
 10.5%                                                   68.8% 
                               ------------------------------- 
 

Awards vest on a straight-line basis between these points.

The awards are subject to Revenue Growth as follows:

 
 Revenue Growth                      Award vesting as a % of salary 
  Three years ended 31 December 
  2025 
 Below Threshold                                                Nil 
                                    ------------------------------- 
 Threshold (-8% of target)                                    17.2% 
                                    ------------------------------- 
 Target - set by reference to 
  our expectations                                            34.4% 
                                    ------------------------------- 
 Maximum or above (+8% of target)                             68.8% 
                                    ------------------------------- 
 

Awards vest on a straight-line basis between these points.

The awards are subject to Cumulative Free Cash Flow as follows:

 
 Cumulative Free Cash Flow            Award vesting as a % of salary 
  Three years ended 31 December 
  2025 
 Below Threshold                                                 Nil 
                                     ------------------------------- 
 Threshold (-20% of target)                                    17.2% 
                                     ------------------------------- 
 Target - set by reference to 
  our expectations                                             34.4% 
                                     ------------------------------- 
 Maximum or above (+10% of target)                             68.8% 
                                     ------------------------------- 
 

Awards vest on a straight-line basis between these points.

Revenue Growth and Cumulative Free Cash Flow targets for the three years ended 31 December 2025 for these awards, even though now determined, will not be disclosed until the 2025 Annual Report, when the Remuneration Committee will discuss performance against the targets. It is not possible to disclose precise targets at the time of grant to avoid giving commercially sensitive information to our competitors concerning our growth plans.

   3.   AWARDS MADE UNDER THE DEFERRED SHARE BONUS PLAN 

On 9 March 2023, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Smith & Nephew Deferred Share Bonus Plan. The awards have been made in London and are based on the closing Share price on the London Stock Exchange on 8 March 2023 of GBP12.09.

i. DEFERRED BONUS PLAN AWARDS GRANTED UNDER THE SMITH & NEPHEW DEFERRED SHARE BONUS PLAN:

A portion of the annual bonus earned by the following Executive Directors for performance during the year to 31 December 2022 has been deferred into a share award. These awards will vest on 9 March 2026 for the Executive Directors, subject to continued achievement of objectives and employment. The participants will be required to hold the shares after tax, for a further period of two years to 9 March 2028. Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------ 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------ 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------ 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc Ordinary Shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            ------------------------------------------ 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------ 
 Nature of the transaction   Deferred Bonus Plan awards granted on 9 
                              March 2023 under the Smith & Nephew plc 
                              Deferred Share Bonus Plan. 
                            ------------------------------------------ 
 Date of Transaction         2023 - 03 - 09 
                            ------------------------------------------ 
 Place of Transaction        Grant took place outside a trading venue 
                            ------------------------------------------ 
 
 
 Name                          Status               Price      Volume(s)   Aggregated information 
  (Position)                                         (s) 
 Deepak Nath                   Executive Director   GBP12.09   26,014      N/A Single Transaction 
  (Chief Executive Officer) 
                              -------------------  ---------  ----------  ----------------------- 
 Anne-Françoise Nesmes    Executive Director   GBP12.09   16,877      N/A Single Transaction 
  ( Chief Financial Officer) 
                              -------------------  ---------  ----------  ----------------------- 
 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVVVFIVLIV

(END) Dow Jones Newswires

March 13, 2023 09:45 ET (13:45 GMT)

Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Smith & Nephew
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Smith & Nephew